Samrat Pharma

{
  "main_header": {
    "sid": 116063,
    "name": "Samrat Pharma",
    "stock_name": "Samrat Pharma",
    "full_name": "Samrat Pharmachem Ltd",
    "name_url": "stocks-analysis/samrat-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "209.95",
    "chg": -17.8,
    "chgp": "-7.82%",
    "dir": -1,
    "prev_price": "227.75",
    "mcapval": "68.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 530125,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE103E01016",
    "curr_date": "Mar 12",
    "curr_time": "",
    "bse_nse_vol": "8.37 k",
    "exc_status": "Active",
    "traded_date": "Mar 12, 2026",
    "traded_date_str": "2026 03 12",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/samrat-pharma-116063-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Samrat Pharmachem Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-samrat-pharmachem-ltd-fallingrising-3886270",
        "imagepath": "",
        "date": "2026-03-12 01:13:20",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Samrat Pharmachem Ltd’s stock price has demonstrated a remarkable short-term recovery, gaining 12.41% over the past week, in stark contrast to the Sensex’s decline of 2.85% during the same period. This outperformance is particularly striking given the stock’s longer-term challenges, including a 28.76% decline over the past year and a 53.27% drop over three years. Despite these setbacks, the stock has managed a 55.25% gain over five years, slightly outperforming the Sensex’s 49.89% rise, indicating some resilience in the broader timeframe.</p>\n<p>The year-to-date performance shows a marginal positive return of 0.20% for Samrat Pharmachem Ltd, while the Sensex has declined by 9.81%, underscoring the stock’s relative strength amid broader..."
      },
      {
        "title": "Samrat Pharmachem Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/samrat-pharmachem-ltd-is-rated-strong-sell-3873120",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SamratPharmache_mojoScore_3873120.png",
        "date": "2026-03-05 10:10:20",
        "description": "Samrat Pharmachem Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 Aug 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Samrat Pharmachem Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/samrat-pharmachem-ltd-is-rated-strong-sell-3850643",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SamratPharmache_mojoScore_3850643.png",
        "date": "2026-02-22 10:10:29",
        "description": "Samrat Pharmachem Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 August 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 23 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Samrat Pharmachem Ltd Faces Sharp Valuation Reassessment Amid Market Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/samrat-pharmachem-ltd-faces-sharp-valuation-reassessment-amid-market-pressure-3843094",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SamratPharmache_valuationdot_3843094.png",
        "date": "2026-02-17 08:00:10",
        "description": "Samrat Pharmachem Ltd has witnessed a significant shift in its valuation parameters, with key metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios deteriorating sharply compared to historical averages and peer benchmarks. This change has coincided with a steep decline in the stock price, prompting a downgrade in its investment grade to Strong Sell by MarketsMOJO as of 19 Aug 2025."
      },
      {
        "title": "Samrat Pharmachem Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/samrat-pharmachem-ltd-is-rated-strong-sell-3830447",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SamratPharmache_mojoScore_3830447.png",
        "date": "2026-02-10 10:10:48",
        "description": "Samrat Pharmachem Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 August 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 10 February 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Samrat Pharmachem Ltd Valuation Shifts Signal Elevated Price Risk Amid Sector Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/samrat-pharmachem-ltd-valuation-shifts-signal-elevated-price-risk-amid-sector-challenges-3815211",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SamratPharmache_valuationdot_3815211.png",
        "date": "2026-02-02 08:00:15",
        "description": "Samrat Pharmachem Ltd’s valuation metrics have recently deteriorated, shifting from expensive to very expensive territory, raising concerns about its price attractiveness amid a challenging sector backdrop and subdued returns relative to benchmarks."
      },
      {
        "title": "Samrat Pharmachem Ltd Falls to 52-Week Low of Rs.195.1 Amidst Continued Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/samrat-pharmachem-ltd-falls-to-52-week-low-of-rs1951-amidst-continued-underperformance-3811614",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SamratPharmache_priceRelatedfactors_3811614.png",
        "date": "2026-01-30 14:15:11",
        "description": "Samrat Pharmachem Ltd’s stock touched a fresh 52-week low of Rs.195.1 today, marking a significant decline amid ongoing challenges in its financial performance and market positioning. This new low reflects a continuation of the stock’s downward trajectory over the past year, with the share price now trading well below all key moving averages."
      },
      {
        "title": "Samrat Pharmachem Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/samrat-pharmachem-ltd-is-rated-strong-sell-3811143",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SamratPharmache_mojoScore_3811143.png",
        "date": "2026-01-30 10:10:35",
        "description": "Samrat Pharmachem Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 August 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 30 January 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Samrat Pharmachem Ltd Stock Falls to 52-Week Low of Rs.199",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/samrat-pharmachem-ltd-stock-falls-to-52-week-low-of-rs199-3805898",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SamratPharmache_priceRelatedfactors_3805898.png",
        "date": "2026-01-27 11:01:33",
        "description": "Samrat Pharmachem Ltd’s stock reached a fresh 52-week low of Rs.199 today, marking a significant decline amid ongoing challenges in the Pharmaceuticals & Biotechnology sector. The stock has underperformed its sector peers and benchmark indices, reflecting persistent pressures on the company’s financial and market metrics."
      }
    ],
    "total": 5743,
    "sid": "116063",
    "stock_news_url": "https://www.marketsmojo.com/news/samrat-pharmachem-116063"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "18-Feb-2026",
      "details": "Newspaper Publication - Extract of Un-audited financial results for the quarter ended 31 December 2025",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held Today",
      "datetime": "13-Feb-2026",
      "details": "The Board has considered and took on record the Un-audited financial results of the company for the quarter ended December 31 2025.",
      "source": "BSE"
    },
    {
      "caption": "Un-Audited Financial Results For The Quarter Ended December 31 2025",
      "datetime": "13-Feb-2026",
      "details": "The Board has considered and took on record the un-audited standalone financial results for the quarter ended December 31 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Samrat Pharmachem Ltd has declared <strong>10%</strong> dividend, ex-date: 18 Sep 25",
          "dt": "2025-09-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Samrat Pharmachem Ltd falling/rising?

2026-03-12 01:13:20

Recent Price Movement and Market Context

Samrat Pharmachem Ltd’s stock price has demonstrated a remarkable short-term recovery, gaining 12.41% over the past week, in stark contrast to the Sensex’s decline of 2.85% during the same period. This outperformance is particularly striking given the stock’s longer-term challenges, including a 28.76% decline over the past year and a 53.27% drop over three years. Despite these setbacks, the stock has managed a 55.25% gain over five years, slightly outperforming the Sensex’s 49.89% rise, indicating some resilience in the broader timeframe.

The year-to-date performance shows a marginal positive return of 0.20% for Samrat Pharmachem Ltd, while the Sensex has declined by 9.81%, underscoring the stock’s relative strength amid broader...

Read full news article

Samrat Pharmachem Ltd is Rated Strong Sell

2026-03-05 10:10:20

Samrat Pharmachem Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 Aug 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Samrat Pharmachem Ltd is Rated Strong Sell

2026-02-22 10:10:29

Samrat Pharmachem Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 August 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 23 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

Samrat Pharmachem Ltd Faces Sharp Valuation Reassessment Amid Market Pressure

2026-02-17 08:00:10

Samrat Pharmachem Ltd has witnessed a significant shift in its valuation parameters, with key metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios deteriorating sharply compared to historical averages and peer benchmarks. This change has coincided with a steep decline in the stock price, prompting a downgrade in its investment grade to Strong Sell by MarketsMOJO as of 19 Aug 2025.

Read full news article

Samrat Pharmachem Ltd is Rated Strong Sell

2026-02-10 10:10:48

Samrat Pharmachem Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 August 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 10 February 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Samrat Pharmachem Ltd Valuation Shifts Signal Elevated Price Risk Amid Sector Challenges

2026-02-02 08:00:15

Samrat Pharmachem Ltd’s valuation metrics have recently deteriorated, shifting from expensive to very expensive territory, raising concerns about its price attractiveness amid a challenging sector backdrop and subdued returns relative to benchmarks.

Read full news article

Samrat Pharmachem Ltd Falls to 52-Week Low of Rs.195.1 Amidst Continued Underperformance

2026-01-30 14:15:11

Samrat Pharmachem Ltd’s stock touched a fresh 52-week low of Rs.195.1 today, marking a significant decline amid ongoing challenges in its financial performance and market positioning. This new low reflects a continuation of the stock’s downward trajectory over the past year, with the share price now trading well below all key moving averages.

Read full news article

Samrat Pharmachem Ltd is Rated Strong Sell

2026-01-30 10:10:35

Samrat Pharmachem Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 August 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 30 January 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Samrat Pharmachem Ltd Stock Falls to 52-Week Low of Rs.199

2026-01-27 11:01:33

Samrat Pharmachem Ltd’s stock reached a fresh 52-week low of Rs.199 today, marking a significant decline amid ongoing challenges in the Pharmaceuticals & Biotechnology sector. The stock has underperformed its sector peers and benchmark indices, reflecting persistent pressures on the company’s financial and market metrics.

Read full news article

View All News